TGFB1 and breast carcinoma: In breast cancer, TGF-β mediates cell cycle arrest by regulating cyclin-dependent kinases and their inhibitors, but altered responsiveness to TGF-β, often due to dysregulation of cell cycle effectors or mutations in TGF-β signaling components, contributes to breast cancer progression [104].